| Typicality: | 0.362 |
| Saliency: | 0.316 |
| in eliminating this difficult problem | 5 | transitive-object |
| in preclinical trials | 5 | location |
| therapy → shown → promise | 15 |
| therapy → shown → great promise | 3 |
| negative | neutral | positive |
| 0.059 | 0.229 | 0.712 |
| Raw frequency | 18 |
| Normalized frequency | 0.316 |
| Modifier score | 0.700 |
| Perplexity | 38.720 |